Form 8-K - Current report:
SEC Accession No. 0001564590-20-017687
Filing Date
2020-04-21
Accepted
2020-04-21 16:06:25
Documents
3
Period of Report
2020-04-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-8k_20200416.htm 8-K 33519
2 EX-10.1 rkda-ex101_6.htm EX-10.1 54669
3 GRAPHIC glkcq4wbb45i000001.jpg GRAPHIC 2228
  Complete submission text file 0001564590-20-017687.txt   92668
Mailing Address 4222 E. THOMAS RD SUITE 320 PHOENIX X1 85018
Business Address 202 COUSTEAU PLACE SUITE 200 DAVIS X1 95618 602-429-0471
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 20805220
SIC: 2870 Agricultural Chemicals